Early Detection of Cancer

• 

  Subject Areas on Research

  • "I Already Know That Smoking Ain't Good for Me": Patient and Clinician Perspectives on Lung Cancer Screening Decision-Making Discussions as a Teachable Moment. 
  • "This is some mess right here": Exploring interactions between Black sexual minority women and health care providers for breast cancer screening and care. 
  • "You start feeling comfortable, you just start sharing:" A qualitative study of patient distress screening in Black and White patients with endometrial cancer. 
  • 'I'm here to save my life': a qualitative study of experiences navigating a cryotherapy referral system for human papillomavirus-positive women in western Kenya. 
  • (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes. 
  • 2017 Version of LI-RADS for CT and MR Imaging: An Update. 
  • A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial. 
  • A Data Set and Deep Learning Algorithm for the Detection of Masses and Architectural Distortions in Digital Breast Tomosynthesis Images. 
  • A Decision Aid to Promote Appropriate Colorectal Cancer Screening among Older Adults: A Randomized Controlled Trial. 
  • A Longitudinal Study of Adenoma Detection Rate in Gastroenterology Fellowship Training. 
  • A National Survey of Pulmonologists' Views on Low-Dose Computed Tomography Screening for Lung Cancer. 
  • A Pilot Study Examining the Efficacy of Delivering Colorectal Cancer Screening Messages via Virtual Health Assistants. 
  • A Procedure for Eliciting Women's Preferences for Breast Cancer Screening Frequency. 
  • A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya. 
  • A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya. 
  • A Summary of the 2020 Gastric Cancer Summit at Stanford University. 
  • A branching process model of ovarian cancer. 
  • A framework for improving early detection of breast cancer in sub-Saharan Africa: A qualitative study of help-seeking behaviors among Malawian women. 
  • A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system. 
  • A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study. 
  • A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision. 
  • A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. 
  • A review of Kenya's cancer policies to improve access to cancer testing and treatment in the country. 
  • A review of cost-effectiveness studies in ovarian cancer. 
  • A study on community perceptions of common cancers, determinants of community behaviour and program implementation in New Delhi, India. 
  • A systematic review of randomized trials assessing human papillomavirus testing in cervical cancer screening. 
  • ACR Appropriateness Criteria® Colorectal Cancer Screening. 
  • ACR Appropriateness Criteria® Lung Cancer Screening. 
  • ACR Appropriateness Criteria® Transgender Breast Cancer Screening. 
  • ACR Appropriateness criteria® for nasopharyngeal carcinoma. 
  • Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. 
  • Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. 
  • Accurate Inputs for Costs and Benefits of Screening Mammography. 
  • Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach. 
  • Acting in the face of uncertainty. 
  • Addressing overdiagnosis and overtreatment in cancer: a prescription for change. 
  • Adherence to Radiology Recommendations in a Clinical CT Lung Screening Program. 
  • Adolescent and young adult oncology. Clinical practice guidelines in oncology. 
  • Adult Patients' Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study. 
  • Adult cancer survivors discuss follow-up in primary care: 'not what i want, but maybe what i need'. 
  • Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool. 
  • American Cancer Society Colorectal Cancer Survivorship Care Guidelines. 
  • American Cancer Society lung cancer screening guidelines. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. 
  • An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. 
  • An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time. 
  • Anal-rectal cytology: a review. 
  • Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer. 
  • Associations between religion-related factors and breast cancer screening among American Muslims. 
  • Associations between religion-related factors and cervical cancer screening among Muslims in greater chicago. 
  • Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value. 
  • Availability and scope of integrated screening for patients with Lynch syndrome. 
  • Awareness of Cervical Cancer Causes and Predeterminants of Likelihood to Screen Among Women in Haiti. 
  • Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. 
  • Barriers and Facilitators to Cervical Cancer Screening in Western Kenya: a Qualitative Study. 
  • Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. 
  • Barriers to Breast and Cervical Cancer Screening in Singapore: a Mixed Methods Analysis. 
  • Barriers to Cervical Cancer Screening in Rural Kenya: Perspectives from a Provider Survey. 
  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. 
  • Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. 
  • Baseline prostate-specific antigen testing at a young age. 
  • Benefits and Harms of Breast Cancer Screening: A Systematic Review. 
  • Benefits and Risks of Mammography Screening in Women Ages 40 to 49 Years. 
  • Beyond Black and White: race and sexual identity as contributors to healthcare system distrust after breast cancer screening among US women. 
  • Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. 
  • Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness. 
  • Breast Cancer Screening and Care Among Black Sexual Minority Women: A Scoping Review of the Literature from 1990 to 2017. 
  • Breast Cancer Screening and Health Care Costs. 
  • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. 
  • Breast Cancer Screening: Benefit or Harm?--Reply. 
  • Breast Imaging for Transgender Individuals: Assessment of Current Practice and Needs. 
  • Breast cancer deaths averted over 3 decades. 
  • Breast cancer detection using high-density flexible electrode arrays and electrical impedance tomography. 
  • Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. 
  • Breast cancer screening with mammography. 
  • Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter? 
  • Breast cancer screening: science, society and common sense. 
  • Breast self-examination: defining a cohort still in need. 
  • Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. 
  • Can portable Colposcopes Replace Standard-of-care Colposcopes? A Crossover Trial of Two Portable Colposcopes with a Standard-of-Care Video Colposcope. 
  • Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings. 
  • Cancer Screening in Primary Care: So Much Progress, So Much Left to Do. 
  • Cancer disparities in people with HIV: A systematic review of screening for non-AIDS-defining malignancies. 
  • Cancer prevention and screening practices of siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study. 
  • Cardiovascular Risk in the Lung Cancer Screening Population: A Multicenter Study Evaluating the Association Between Coronary Artery Calcification and Preventive Statin Prescription. 
  • Care and Cancer Screening of the Transgender Population. 
  • Cervical Cancer Screening Knowledge and Behavior among Women Attending an Urban HIV Clinic in Western Kenya. 
  • Cervical Cancer Screening and Follow-Up Practices in U.S. Prisons. 
  • Cervical Cancer Screening. 
  • Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It? 
  • Cervical Cancer-Related Knowledge, Attitudes, Practices and Self-Screening Acceptance Among Patients, Employees, and Social Media Followers of Major Brazilian Hospital. 
  • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. 
  • Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. 
  • Changing knowledge, attitudes, and behaviors regarding cervical cancer screening: The effects of an educational intervention in rural Kenya. 
  • Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. 
  • Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women. 
  • Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions. 
  • Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study. 
  • Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer. 
  • Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial. 
  • Clinical Trial Protocol for a Randomized Trial of Community Health Worker-led Decision Coaching to Promote Shared Decision-making on Prostate Cancer Screening Among Black Male Patients and Their Providers. 
  • Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. 
  • Clinician interest in clinical decision support for PSA-based prostate cancer screening. 
  • Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy. 
  • Colorectal Cancer Screening in a Nationwide High-deductible Health Plan Before and After the Affordable Care Act. 
  • Colorectal Cancer Screening: A Quality Improvement Initiative Using a Bilingual Patient Navigator, Mobile Technology, and Fecal Immunochemical Testing to Engage Hispanic Adults. 
  • Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. 
  • Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. 
  • Combining multiple contrasts for improving machine learning-based classification of cervical cancers with a low-cost point-of-care Pocket colposcope. 
  • Commentary: Safety first! 
  • Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019. 
  • Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. 
  • Comparison of DRE and PSA in the Detection of Prostate Cancer. 
  • Comparison of Outcomes for One-View Asymmetries Recalled From Digital Breast Tomosynthesis Versus Full-Field Digital Mammography Screening Examinations. 
  • Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study. 
  • Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study. 
  • Computed tomography screening for lung cancer: where are we now? 
  • Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer. 
  • Considerations of germline testing in prostate cancer screening. 
  • Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. 
  • Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare. 
  • Controversies in Breast Cancer Screening Strategies. 
  • Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer. 
  • Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. 
  • Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors. 
  • Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening. 
  • Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program. 
  • Costs of integrating cervical cancer screening at an HIV clinic in Kenya. 
  • Creating value in health by understanding and overcoming resistance to de-innovation. 
  • Decision making about cancer screening: an assessment of the state of the science and a suggested research agenda from the ASPO Behavioral Oncology and Cancer Communication Special Interest Group. 
  • Deep learning model to quantify left atrium volume on routine non-contrast chest CT and predict adverse outcomes. 
  • Deep learning on time series laboratory test results from electronic health records for early detection of pancreatic cancer. 
  • Defining low-value PSA testing in a large retrospective cohort: Finding common ground between discordant guidelines. 
  • Demand for Cancer Screening Services: Results From Randomized Controlled Discrete Choice Experiments. 
  • Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis. 
  • Detection and localization of surgically resectable cancers with a multi-analyte blood test. 
  • Detection of early-stage pancreatic adenocarcinoma. 
  • Developing a framework to describe stigma related to cervical cancer and HPV in western Kenya. 
  • Development of Algorithms for Automated Detection of Cervical Pre-Cancers With a Low-Cost, Point-of-Care, Pocket Colposcope. 
  • Development of a multimarker assay for early detection of ovarian cancer. 
  • Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction. 
  • Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations. 
  • Diabetic biomarkers and the risk of proximal or distal gastric cancer. 
  • Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy. 
  • Diagnostic Versus Screening Mammography Recommendations for Postlumpectomy Imaging Surveillance of Patients With Breast Cancer. 
  • Digital Breast Tomosynthesis and Detection of Interval Invasive and Advanced Breast Cancers. 
  • Disparities in the uptake of digital breast tomosynthesis for breast cancer screening: A retrospective cohort study. 
  • Distress screening in endometrial cancer leads to disparity in referral to support services. 
  • Does it pay to pay people to share information? Using financial incentives to promote peer referral for mammography among the underinsured. 
  • Ductal Carcinoma in Situ: State-of-the-Art Review. 
  • Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. 
  • Early detection of lung cancer in a population at high risk due to occupation and smoking. 
  • Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis. 
  • Editorial Comment. 
  • Editorial comment. 
  • Effect of a Patient Decision Aid on Preferences for Colorectal Cancer Screening Among Older Adults: A Secondary Analysis of a Randomized Clinical Trial. 
  • Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 
  • Estimating the frequency of indolent breast cancer in screening trials. 
  • Estimating the magnitude of clinical benefit of local therapy in patients with DCIS. 
  • Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort. 
  • Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort. 
  • Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. 
  • Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study. 
  • Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. 
  • Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer. 
  • Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms. 
  • Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center. 
  • Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer. 
  • Experience with a CT screening program for individuals at high risk for developing lung cancer. 
  • Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening. 
  • Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States. 
  • Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial. 
  • Factors associated with appropriate and low-value PSA testing. 
  • Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic. 
  • False Information About Breast Cancer Screening. 
  • Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. 
  • Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video). 
  • Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya. 
  • Focal therapy for prostate and renal cancer--are we ready for it? 
  • Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer. 
  • Frequency of Breast Cancer Thoughts and Lifetime Risk Estimates: A Multi-Institutional Survey of Women Undergoing Screening Mammography. 
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. 
  • Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening. 
  • General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. 
  • Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 
  • Genetically Informed Prostate Cancer Screening. 
  • Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility. 
  • Getting beyond screening for frailty in older patients with cancer. 
  • Global ovarian cancer health disparities. 
  • HPV-based cervical cancer screening in low-resource settings: Maximizing the efficiency of community-based strategies in rural Kenya. 
  • Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia. 
  • Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. 
  • Health economics of screening for gynaecological cancers. 
  • Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. 
  • Hepatocellular Carcinoma Surveillance. 
  • High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. 
  • How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya. 
  • How does information on the harms and benefits of cervical cancer screening alter the intention to be screened?: a randomized survey of Norwegian women. 
  • Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk. 
  • Human papillomavirus in early laryngeal carcinoma. 
  • Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials. 
  • Impact of Breast Density Notification Legislation on Radiologists' Practices of Reporting Breast Density: A Multi-State Study. 
  • Impact of Improved Screening Mammography Recall Lay Letter Readability on Patient Follow-Up. 
  • Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. 
  • Impact of Telephone Communication on Patient Adherence With Follow-Up Recommendations After an Abnormal Screening Mammogram. 
  • Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data. 
  • Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. 
  • Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment. 
  • Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database. 
  • Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007. 
  • Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network. 
  • Implementation of Abbreviated Breast MRI for Screening: AJR Expert Panel Narrative Review. 
  • Implementation of Lung Cancer Screening in the Veterans Health Administration. 
  • Implementation of new clinical programs in the VHA healthcare system: the importance of early collaboration between clinical leadership and research. 
  • Implementing a mHealth intervention to increase colorectal cancer screening among high-risk cancer survivors treated with radiotherapy in the Childhood Cancer Survivor Study (CCSS). 
  • Improving Access to Cancer Testing and Treatment in Kenya. 
  • Improving State-Mandated Breast Density Notifications. 
  • In Estimating Overdiagnosis, Details Matter. 
  • In defense of screening for breast cancer with magnetic resonance imaging--reply. 
  • Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System. 
  • Initial outcomes and insights from a novel high-risk prostate cancer screening clinic. 
  • Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. 
  • Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography. 
  • Integration of Anal Dysplasia Screening into the Primary Care of Persons Living with HIV. 
  • International Image Concordance Study to Compare a Point-of-Care Tampon Colposcope With a Standard-of-Care Colposcope. 
  • Interventions designed to increase the uptake of lung cancer screening and implications for priority populations: a scoping review protocol. 
  • Interventions to improve lung cancer screening among racially and ethnically minoritized groups: A scoping review. 
  • Investigation momentum: the relentless pursuit to resolve uncertainty. 
  • Is There a Role for Ovarian Cancer Screening in High-Risk Women? 
  • Issues with implementing a high-quality lung cancer screening program. 
  • It's the amount of thought that counts: when ambivalence contributes to mammography screening delay. 
  • Knowledge about cervical cancer screening and perception of risk among women attending outpatient clinics in rural Kenya. 
  • Knowledge, attitudes, and practices regarding cervical cancer screening among women in metropolitan Lima, Peru: a cross-sectional study. 
  • Lay Health Worker-Led Cancer Symptom Screening Intervention and the Effect on Patient-Reported Satisfaction, Health Status, Health Care Use, and Total Costs: Results From a Tri-Part Collaboration. 
  • Letter to the Editor - "Is it ethical to incentivize mammography screening in Medicaid populations? - A policy review and conceptual analysis". 
  • Letters of Correspondence: Telehealth, Post-Acute Sequelae of COVID-19, Lung Cancer Screening Rates. 
  • Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk. 
  • Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. 
  • Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. 
  • Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort. 
  • Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality. 
  • Low-Dose Computed Tomography: Effects of Oncology Nurse Navigation on Lung Cancer Screening. 
  • Low-dose computed tomographic screening for lung cancer. 
  • Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort. 
  • Lung Cancer Screening Eligibility and Use: A Population Health Perspective of One Community. 
  • Lung Cancer Screening in Never Smokers: Counterpoint-Cannot Identify Which Never Smokers Are at Sufficient Risk to Balance the Potential Harms of Screening. 
  • Lung Cancer Screening with Chest CT: Efficacy Confirmed. 
  • Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. 
  • Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. 
  • Lung cancer management in 2010. 
  • Lung cancer mortality among construction workers: implications for early detection. 
  • Lung cancer screening: No more excuses. 
  • Mass detection on mammograms: influence of signal shape uncertainty on human and model observers. 
  • Maximum-Intensity-Projection and Computer-Aided-Detection Algorithms as Stand-Alone Reader Devices in Lung Cancer Screening Using Different Dose Levels and Reconstruction Kernels. 
  • Measuring the quality of Barrett's esophagus management with measures that are high quality. 
  • Medicaid Expansion and Breast Cancer Screening in Appalachia and Non-Appalachia, United States, BRFSS 2003 to 2015. 
  • Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program. 
  • Men's knowledge and attitudes about cervical cancer screening in Kenya. 
  • Methods of Melanoma Detection. 
  • Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study. 
  • Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review. 
  • Modeling the natural history of ductal carcinoma in situ based on population data. 
  • Modernizing the diagnostic and decision-making pathway for prostate cancer. 
  • Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. 
  • Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer. 
  • Most of patients with localized prostate cancer will be treated in the future? | Opinion: No. 
  • Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma. 
  • NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. 
  • NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. 
  • NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening. 
  • NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. 
  • NCCN clinical practice guidelines in oncology: prostate cancer early detection. 
  • NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. 
  • Nano-architectural alterations in mucus layer fecal colonocytes in field carcinogenesis: potential for screening. 
  • Narratives that address affective forecasting errors reduce perceived barriers to colorectal cancer screening. 
  • National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. 
  • National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. 
  • National trends and disparities in cervical cancer screening among commercially insured Women, 2001-2010. 
  • Negative controls to detect uncontrolled confounding in observational studies of mammographic screening comparing participants and non-participants. 
  • Non-communicable chronic diseases and timely breast cancer screening among women of the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study. 
  • Nuclear morphology measurements with angle-resolved low coherence interferometry for application to cell biology and early cancer detection. 
  • Nuclear morphology measurements with angle-resolved low coherence interferometry for application to cell biology and early cancer detection. 
  • Obesity and receipt of clinical preventive services in veterans. 
  • Organ doses from CT localizer radiographs: Development, validation, and application of a Monte Carlo estimation technique. 
  • Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania. 
  • Ovarian cancer, version 3.2012. 
  • Palliative care. 
  • Pathologic basis of focal therapy for early-stage prostate cancer. 
  • Patient Preferences for Outcomes Following DCIS Management Strategies: A Discrete Choice Experiment. 
  • Patient and Radiologist Demographics Influence Perceptions of Screening Mammography Reports. 
  • Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial. 
  • Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study. 
  • Patient-physician communication about early stage prostate cancer: analysis of overall visit structure. 
  • Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic. 
  • Patterns of breast magnetic resonance imaging use: an opportunity for data-driven resource allocation. 
  • Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. 
  • Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study. 
  • Physicians' attitudes about shared decision making for prostate cancer screening. 
  • Pilot study of rapid MR pancreas screening for patients with BRCA mutation. 
  • Policy Considerations to Promote Equitable Cervical Cancer Screening and Treatment in Peru. 
  • Portable Pocket colposcopy performs comparably to standard-of-care clinical colposcopy using acetic acid and Lugol's iodine as contrast mediators: an investigational study in Peru. 
  • Post-radical prostatectomy management options for positive surgical margins: argument for observation. 
  • Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months? 
  • Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. 
  • Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 
  • Predicting Colorectal Cancer Screening among Adults Who Have Never Been Screened: Testing the Interaction between Message Framing and Tailored Risk Feedback. 
  • Predictive value of digital rectal examination for prostate cancer detection is modified by obesity. 
  • Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer. 
  • Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 
  • Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. 
  • Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting. 
  • Predictors of surveillance mammography outcomes in women with a personal history of breast cancer. 
  • Predisease: when does it make sense? 
  • Prevention and early detection of cancer. 
  • Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus. 
  • Primary care perspective and implementation of a multidisciplinary, institutional prostate cancer screening algorithm embedded in the electronic health record. 
  • Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. 
  • Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor Study. 
  • Propensity score weighting with multilevel data. 
  • Prospective Multisite Cohort Study to Evaluate Shared Decision-Making Utilization Among Individuals Screened for Lung Cancer. 
  • Prostate Cancer National Summit's Call to Action. 
  • Prostate Cancer Screening for Gay Men in the United States. 
  • Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. 
  • Prostate cancer in young men: an important clinical entity. 
  • Prostate cancer screening. 
  • Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone. 
  • Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men. 
  • Protocol to evaluate an enterprise-wide initiative to increase access to lung cancer screening in the Veterans Health Administration. 
  • Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. 
  • Quantification of Aortic Valve Calcifications Detected During Lung Cancer-Screening CT Helps Stratify Subjects Necessitating Echocardiography for Aortic Stenosis Diagnosis. 
  • Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening. 
  • Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers. 
  • Rapid determination of oxygen saturation and vascularity for cancer detection. 
  • Rationale and Design of the Lung Cancer Screening Implementation. Evaluation of Patient-Centered Care Study. 
  • Reactions to online colorectal cancer risk estimates among a nationally representative sample of adults who have never been screened. 
  • Readiness for Implementation of Lung Cancer Screening. A National Survey of Veterans Affairs Pulmonologists. 
  • Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study. 
  • Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. 
  • Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe. 
  • Reduced Mammography Screening for Breast Cancer among Women with Visual Impairment. 
  • Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening. 
  • Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk. 
  • Relationship between prostate-specific antigen, age, and body mass index in a prostate cancer screening population. 
  • Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough. 
  • Rigor in Quality Improvement Studies and the Role of Time-Series Methodologies. 
  • Risk perception measures' associations with behavior intentions, affect, and cognition following colon cancer screening messages. 
  • Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution. 
  • Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules. 
  • Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. 
  • Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini Institute. 
  • Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality. 
  • Screening and prevention measures for melanoma: is there a survival advantage? 
  • Screening for Breast Cancer in Average-Risk Women. 
  • Screening for cervical cancer: a modeling study for the US Preventive Services Task Force. 
  • Screening for familial and hereditary prostate cancer. 
  • Screening mammography for average-risk women. 
  • Screening mammography use in older women according to health status: a systematic review and meta-analysis. 
  • Secondary screening tests for prostate cancer: is more information better? Which test is best? 
  • Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data. 
  • Simulation optimization of PSA-threshold based prostate cancer screening policies. 
  • Skin Cancer Risk Factors and Screening Among Asian American Individuals. 
  • Skin cancer in the military: A systematic review of melanoma and nonmelanoma skin cancer incidence, prevention, and screening among active duty and veteran personnel. 
  • Social Disparities in Lung Cancer Risk and Screening. 
  • Society of Behavior Medicine (SBM) Urges Congress to Ensure Affordable Care Act Coverage of Prostate Cancer Screening Support Services for High-Risk Men. 
  • Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey. 
  • Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. 
  • Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer. 
  • Study Design and Rationale: A Multicenter, Prospective Trial of Electromagnetic Bronchoscopic and Electromagnetic Transthoracic Navigational Approaches for the Biopsy of Peripheral Pulmonary Nodules (ALL IN ONE Trial). 
  • Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. 
  • Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. 
  • Survival is not the only valuable end point in melanoma screening. 
  • Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies. 
  • Ten or More Cumulative Lifetime Adenomas Are Associated with Increased Risk for Advanced Neoplasia and Colorectal Cancer. 
  • Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia. 
  • The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease. 
  • The Importance of Cancer Screening. 
  • The International Association for the Study of Lung Cancer Early Lung Imaging Confederation. 
  • The association between individual time preferences and health maintenance habits. 
  • The development of a web- and a print-based decision aid for prostate cancer screening. 
  • The effect of Medicare Advantage enrollment on mammographic screening. 
  • The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. 
  • The role of perceived benefits and costs in patients' medical decisions. 
  • The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma. 
  • The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. 
  • To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions. 
  • Total and Out-of-Pocket Costs of Procedures After Lung Cancer Screening in a National Commercially Insured Population: Estimating an Episode of Care. 
  • Towards Prevention of Breast Cancer: What Are the Clinical Challenges? 
  • Towards a field-compatible optical spectroscopic device for cervical cancer screening in resource-limited settings: effects of calibration and pressure. 
  • Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. 
  • Triaging Patient Scheduling Can Minimize the Risks of Breast Cancer Screening Programs. 
  • Two weights make a wrong: Cluster randomized trials with variable cluster sizes and heterogeneous treatment effects. 
  • Two-year trends in cancer screening among low socioeconomic status women in an HMO-based high-deductible health plan. 
  • Unique Primary Care Needs of Transgender and Gender Non-Binary People. 
  • Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative. 
  • Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group. 
  • Updates in colorectal cancer screening in inflammatory bowel disease. 
  • Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya. 
  • Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. 
  • Use of detailed family history data to improve risk prediction,with application to breast cancer screening. 
  • Use of pulmonary function test demographic data to identify high-risk patients for lung cancer screening. 
  • Using real-world evidence to support a changing paradigm for cancer screening: A commentary. 
  • Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population. 
  • Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. 
  • Valuations of genetic test information for treatable conditions: the case of colorectal cancer screening. 
  • What Women and Their Physicians Need to Know About the UKCTOCS Study and Ovarian Cancer Screening. 
  • What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. 
  • Why information alone is not enough: behavioral economics and the future of genomic medicine. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Cohen, Seth Morris, Professor of Head and Neck Surgery & Communication Sciences, Head and Neck Surgery & Communication Sciences
  • Colsher, James George, Adjunct Assistant Professor in the Department of Radiology, Radiology
  • Gellad, Ziad F., Associate Professor of Medicine, Medicine, Gastroenterology
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Halstater, Brian Hugh, Associate Professor of Family Medicine and Community Health, Family Medicine and Community Health, Family Medicine
  • Lee, Walter T, Professor of Head and Neck Surgery & Communication Sciences, Radiation Oncology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Roy Choudhury, Kingshuk, Adjunct Associate Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Stouder, April Loehmer, Associate Professor in Family Medicine and Community Health, Family Medicine and Community Health, Physician Assistant Program
  • Wax, Adam P., Professor of Biomedical Engineering, Biomedical Engineering
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine
  • Zafar, Syed Yousuf, Adjunct Professor in the Department of Medicine, Duke Science & Society